Intracoronary
Diagnostic Strategy
Introducing Raywatt’s innovative FASTER OCT system for swift and
accurate cardiovascular diagnosis. FASTER OCT offers world-leading
imaging technology at 400 frames per second, using saline to greatly
reduce patient side effects and complications. It not only provides
high-resolution images but also performs detailed analysis, swiftly
delivering crucial medical information to users. With its definitive
diagnosis, FASTER OCT aids in fast patient treatment.
From groundbreaking speed to transformative treatment,
we lead the way in revolutionizing.
More Info.
Raywatt Inc., a medical device company, showcased its technology at EuroPCR 2025 in France, aiming to expand global partnerships and diversify export markets.
2025-05-28 News 1
Raywatt announced on Monday that it has attracted a total of 8.5 billion won worth of Series A investment. The investment was decided in recognition of Ray Watt's growth potential of OCT-based cardiovascular diagnosis technology and artificial intelligence (AI) solutions.
2024-02-27 maekyung
Raywatt, a cardiovascular intervention medical device development company, has attracted 2 billion KRW in investment from Korea Investment Partners in the Series A phase.
2024-12-30 The Hankyung
Raywatt, a company specializing in intelligent cardiovascular imaging diagnostic medical devices, announced on the 30th that the company's cardiovascular OCT (optical coherence tomography) imaging device 'FASTER' won the 'Red Dot Award: Design Concept 2024'.
2024-07-30 Red dot
Raywatt will present its high-resolution cardiovascular OCT technology, 'FASTER,' at TCT 2024, highlighting its superior imaging and AI-based FFR capabilities for improved diagnosis and treatment.
2024-10-18 OCT News
Raywatt will present its high-resolution cardiovascular OCT technology, 'FASTER,' at TCT 2024, highlighting its superior imaging and AI-based FFR capabilities for improved diagnosis and treatment.
2024-10-16 The JoongAng
We strive to be accountable in every
aspect of our business, from product
development to customer support.
This sense of accountability is what
drives us to provide the highest quality
cardiovascular OCT equipment.
We continuously invest in research and development to push the boundaries of intravascular imaging technology. We are committed to finding innovative breakthroughs from a fresh perspective to meet any requirements for patient treatment.
We believe that by working together, sharing knowledge, and harnessing collective expertise, we can achieve great accomplishments in advancing intravascular OCT technology and improving the treatment environment for patients.
